PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
Search by company or clause
Video walkthroughs
Podcast episodes
MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
🔒 Subscribers only
AUTH/3775/6/23
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca
An anonymous complainant alleged that a UK-based global senior colleague ‘liked’ a LinkedIn post about Breztri, thereby promoting a medicine to the public. The original LinkedIn post was made o…
Clauses: NONE
🔒 Subscribers only
AUTH/3867/12/23
Social Media & Digital Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk breached ABPI Code after employee reposted Financial Times LinkedIn post mentioning Weg
An anonymous, non-contactable complainant (self-described health professional) raised concerns about a Novo Nordisk employee’s LinkedIn activity involving a Financial Times (FT) post.The employee…
🔒 Subscribers only
AUTH/3788/6/23
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AstraZeneca
A health professional complained about the “SPONSORED” section of a third-party publisher’s email newsletter. The sponsored content block read: “Sponsored: See Beyond Sugar: Using NICE NG28…
Clauses: NONE
🔒 Subscribers only
AUTH/3778/6/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An article titled ‘Exploring the potential of remote atrial fibrillation diagnosis through digital technology’ was published in Cardiac Rhythm News (August 2021).The opportunity arose after Dai…
Clauses: NONE
🔒 Subscribers only
AUTH/3770/5/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi Sankyo
An anonymous complainant alleged that a Nilemdo/Nustendi promotional website suggested Nustendi could be added to statins without stating a key contraindication from the Nustendi SmPC.The contraind…
Clauses: NONE
🔒 Subscribers only
AUTH/3779/6/23
Off-label Promotion Not Upheld 🏥 Diabetes ▶ Video 🎙 Podcast
AUTH/3779/6/23 & AUTH/3780/6/23
An anonymous, non-contactable complainant (described as a former employee) raised concerns about the promotional material approval process (PMAP) used within the Boehringer Ingelheim (BI) and Eli L…
Clauses: NONE
🔒 Subscribers only
AUTH/3799/7/23
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Grünenthal voluntary admission
Grünenthal made a voluntary admission about an employee in Market Access whose role involved calling on health professionals.The employee started employment in February 2022 but did not start/take…
Clauses: 10.2
🔒 Subscribers only
AUTH/3834/10/23
Social Media & Digital Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
AbbVie
AbbVie made a voluntary admission after, during its response to another PMCPA case (AUTH/3834/10/23), it identified that a ‘Clear Horizons’ registration webpage for UK health professionals had …
🔒 Subscribers only
AUTH/3728/1/23
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Bristol Myers Squibb
A complaint was made alleging promotion of Zeposia (ozanimod hydrochloride) by Bristol Myers Squibb.Complaint received: 11 January 2023.Case completed: 20 February 2024.
Clauses: NONE
🔒 Subscribers only
AUTH/3786/6/23
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
AbbVie
An anonymous, contactable complainant raised concerns about a 2022 episode of a popular national television quiz show featuring an AbbVie senior global medical affairs employee based in the UK.On t…
Clauses: NONE
🔒 Subscribers only
AUTH/3777/6/23
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca Trixeo eligibility checklist
An anonymous, contactable complainant (self-described health professional) challenged a UK HCP promotional website resource: a Trixeo (formoterol fumarate dihydrate/glycopyrronium/budesonide) “pa…
Clauses: NONE
🔒 Subscribers only
AUTH/3801/7/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
An anonymous complainant alleged a very senior UK-based AstraZeneca leader’s LinkedIn profile ‘About’ section referenced multiple AstraZeneca medicines by brand name (eg Tagrisso, Imfinzi, Im…
Clauses: NONE
🔒 Subscribers only
AUTH/3729/1/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
Complaint 1 (Jan 2022 webinar): A UK virtual “Early Stage Think Tank”/“Surgical Think Tank” meeting was presented as non-promotional, but the Panel considered it promotional given the conte…
Clauses: NONE
🔒 Subscribers only
AUTH/3774/6/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
An anonymous, contactable complainant (who later became non-contactable) complained about senior global UK-based AstraZeneca employees’ activity on LinkedIn.Two historical LinkedIn posts were cit…
Clauses: NONE
🔒 Subscribers only
AUTH/3785/6/23
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK breached ABPI Code over “Trevor trusts Trelegy” website claim (AUTH/3785/6/23)
An anonymous complainant challenged promotional content for Trelegy on GSK’s HCP-facing website (GSKPro).The webpage headline claim stated: “Trevor trusts Trelegy*”, with a qualifier: “*But…
Clauses: NONE
🔒 Subscribers only
AUTH/3781/6/23
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GSK fined for ambiguous Trelegy website claim implying significant exacerbation reduction vs unnamed
An anonymous, contactable health professional complained about a promotional claim on GSK’s HCP website (GSK.pro) for Trelegy Ellipta.The headline claim stated: “Trelegy demonstrated greater an…
Clauses: NONE
🔒 Subscribers only
AUTH/3813/8/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
AstraZeneca
A third-party institution posted on LinkedIn about a pre-clinical study discussing resistance to osimertinib and how it might be reversed/restored in certain EGFR-mutant lung tumours.Three UK-based…
Clauses: NONE
🔒 Subscribers only
AUTH/3810/8/23
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
GSK
An anonymous, non-contactable complainant (ex-employee) alleged a GSK employee shared a LinkedIn post about Jemperli’s (dostarlimab) US licence expansion, linking to a GSK press release, and that…
Clauses: NONE
🔒 Subscribers only
AUTH/3816/7/23
Social Media & Digital Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Stirling Anglian breached Clause 12.9 after omitting adverse event reporting statement from Acepiro
An anonymous, non-contactable complainant queried a digital banner advertisement for Acepiro (acetylcysteine) on a learned society’s website, noting the absence of a “safety statement” in the…
Clauses: 12.9
🔒 Subscribers only
AUTH/3789/7/23
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Moderna
An anonymous, non-contactable complainant submitted a November 2021 presentation titled “E-concent management – Manual process”.The presentation described a regional proposal for obtaining HC…
Clauses: NONE
🔒 Subscribers only
AUTH/3818/9/23
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Complainant v GSK
A complaint was made against GSK concerning allegations about a webpage.The PMCPA assessed whether the matter fell within the scope of the ABPI Code of Practice.
🔒 Subscribers only
AUTH/3836/10/23
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
GSK breached ABPI Code over Zejula AE management webpage that omitted discontinuation scenarios
An anonymous, contactable health professional complained about a GSK promotional webpage for Zejula (niraparib) on the GSKPro site, titled “PRIMA AE management”.The webpage stated: “If your p…
Clauses: NONE
🔒 Subscribers only
AUTH/3839/10/23
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Ipsen
Ipsen identified (via an internal audit) that one employee in a promotional, customer-facing role calling on health professionals in Northern Ireland had no ABPI representative exam certificate on …
🔒 Subscribers only
AUTH/3804/7/23
HCP Hospitality & Meetings Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Ethypharm
A group of health professionals from an NHS Health Board complained about the conduct of an Ethypharm Key Account Manager/representative in relation to the Aurum range of prefilled syringes (Calciu…
Clauses: NONE
← Prev 2 3 4 5 6 7 8 Next → Page 5 of 73 — 1752 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews